A study by McCarthy et al. presented increased cholesterol efflux in Csf2rb−/− AMs ex vivo, decreased cholesterol accumulation and amelioration of PAP in vivo and finally also therapeutic benefit and improved radiological findings in PAP patients under statin therapy [73]. The gene discussed is CSF2RB; the disease is pulmonary alveolar proteinosis.